Expert Q&A
An Update on Ketamine
Benjamin D. Brody, MD
Associate Professor of Clinical Psychiatry, Weill Cornell Medical College.
Dr. Brody has no financial relationships with companies related to this material.
Items Tagged with 'treatment-resistant depression'
ARTICLES
Research Update
Pramipexole Shows Consistent Antidepressant Benefits Across Two RCTs, But Side Effects Limit Use
Edited by Jesse Koskey, MD. Dr. Koskey has no financial relationships with companies related to this material.
Research Update
Selegiline Patch May Offer Safer Option for Treatment-resistant Depression
Alla Alexander, MD. Dr. Alexander has no financial relationships with companies related to this material.
Expert Q&A
Ketamine Treatment in Inpatient Psychiatry: What Clinicians Need to Know
Benjamin D. Brody, MD. Associate Professor of Clinical Psychiatry; Service Chief, Acute Care Services, Department of Psychiatry, Weill Cornell Medicine, New York, NY.
Dr. Brody has no financial relationships with companies related to this material.
Expert Q&A
Beyond Meds: TMS in Acute Psychiatric Care
Nicholas Trapp, MD, MS
Assistant Professor of Psychiatry; Director, Electroconvulsive Therapy Services, University of Iowa Health Care, Iowa City, IA.
Dr. Trapp has no financial relationships with companies related to this material.
Research Update
Ketamine Shows Only Modest Advantage Over Midazolam in Inpatient Depression Treatment
Victoria Hendrick, MD. Dr. Hendrick has no financial relationships with companies related to this material.
Try The New AskCarlat AI
Recommended
